Vir Biotechnology Inc (VIR)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,150,380 | 1,590,240 | 2,077,960 | 1,431,850 | 716,852 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,150,380K)
= 0.00
Based on the data provided, Vir Biotechnology Inc has consistently maintained a debt-to-capital ratio of 0.00 over the past five years, from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its operations during this period, and its capital structure is predominantly reliant on equity. A debt-to-capital ratio of 0.00 signifies that there is no financial leverage in the company's capital structure, which may point towards a conservative approach to managing its financial obligations and a lower risk of financial distress associated with high debt levels. However, it's important to note that while a low debt-to-capital ratio can be beneficial in terms of financial stability, it may also imply missed opportunities for growth or leveraging favorable debt financing options.
Peer comparison
Dec 31, 2024